SUSQUEHANNA INTERNATIONAL GROUP, LLP, a registered investment adviser, initiated a new position in Eli Lilly and Company (NYSE:LLY) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 3,847,900 shares of the Healthcare company, valued at approximately $4.1B as of the filing date.
Eli Lilly and Company's stock currently trades at $1021.94 with a market capitalization of $906.5B.


